trending Market Intelligence /marketintelligence/en/news-insights/trending/FCvuRPbKub7woz8EA-VtYQ2 content esgSubNav
In This List

Wolfe Research upgrades Charles Schwab, downgrades Lazard

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Banking Essentials Newsletter: July Edition - Part 3

Blog

Banking Essentials Newsletter: July Edition - Part 2

Blog

Anticipate the Unknown Go Beyond Fundamentals to Uncover Early Signs of Private Company Credit Deterioration


Wolfe Research upgrades Charles Schwab, downgrades Lazard

Steven Chubak of Wolfe Research LLC upgraded Charles Schwab Corp.'s stock rating to "peer perform" from "underperform," and lowered the price target to $47 from $53.

Chubak believes that the company's earning resilience is undervalued.

The analyst's EPS estimates for the company are $2.72 for 2019 and $3 for 2020.

--------------------------------

The analyst also upgraded Evercore Inc.'s stock rating to "peer perform" from "underperform," and lowered the price target to $82 from $91.

He is of the thought that the company's pay-for-production model should afford it better competitive flexibility in case a slowdown occurs.

The analyst's EPS estimates for the company are $6.97 for 2019 and $7.08 for 2020.

--------------------------------

The Wolfe Research analyst downgraded Lazard Ltd.'s stock rating to "underperform" from "peer perform," and lowered the price target to $39 from $46.

Chubak is cautious on the company's stock, considering risk of higher earnings drawdown in a recession and the decreasing expectation for the company's management to pursue strategic goals, among other things.

The analyst's EPS estimates for the company are $3.98 for 2019 and $3.86 for 2020.

--------------------------------

Northern Trust Corp.'s stock rating was downgraded from "peer perform" to "underperform" by Chubak, who also lowered the price target to $88 from $109.

Chubak believes that there is a greater risk of fall in revenue in a scenario where Northern Trust is more sensitive to equity market levels.

The analyst's EPS estimates for the company are $6.80 for 2019 and $7.50 for 2020.